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Abstract Postmortem brain tissue has been reported
to be suitable to delineate regional pattern of possible
disturbances underlying epigenetic functionality. How-
ever, from many parameters that have been detected
in postmortem brain regions it is noteworthy that an
effect of postmortem interval (PMI), storage time and
premortem parameters should not be underestimated.
Our previous investigation revealed that tryptophan
(TRP) levels in postmortem brain tissue is affected by
PMI and storage time. Since, alteration in TRP levels are
assumed to be due to protein degradation, we further
investigated whether TRP correlates to variables such as
RNA, proteins and DNA modulators. In addition, we
aimed to elucidate whether established postmortem
variables may influence epigenetic parameters. These
were investigated in well characterized postmortem
human brain tissue originating from the European Brain
Bank consortium II (BNEII). We could confirm previ-
ous findings, in which some protein levels alter because
of prolonged PMI. Similarly, we demonstrated an
influence of increased storage period on TRP levels,
which might indicate degradation of proteins. Still not
all proteins degrade in a similar manner, therefore a
specific analysis for the protein of interest would be
Camelia Maria Monoranu, Edna Gru¨nblatt, contributed equally
and to be considered as equal first authors.
Isidro Ferrer, Peter Riederer, to be considered as equal last
authors.
Camelia Maria Monoranu, Edna Gru¨nblatt, Safa Al-Saraj,
Andrea Schmitt, Peter Falkai, Wolfgang Roggendorf, Isidro
Ferrer, Peter Riederer—Member of BrainNet Europe II
Consortium (BrainNet Europe http://www.brainnet-
europe.org).
Electronic supplementary material The online version of
this article (doi:10.1007/s10561-010-9199-z) contains supple-
mentary material, which is available to authorized users.
E. Gru¨nblatt  J. Bartl  A. Meyer  D. Keller 
T. M. Michel  J. Deckert  P. Riederer
Clinical Neurochemistry, National Parkinson Foundation
Centre of Excellence Research Laboratory, Clinic and
Policlinic for Psychiatry, Psychosomatic and
Psychotherapy, University of Wu¨rzburg, Wu¨rzburg,
Germany
C. M. Monoranu  W. Roggendorf
Department of Neuropathology, Institute of Pathology,
University of Wu¨rzburg, Wu¨rzburg, Germany
M. Apfelbacher
Institute of Legal Medicine, University of Wu¨rzburg,
Wu¨rzburg, Germany
I. Ferrer
Institut de Neuropatologia, Hospital Universitari de
Bellvitge, Universitat de Barcelona, Barcelona, Spain
A. Schmitt
Laboratory of Neuroscience (LIM27),
Institute of Psychiatry, University of Sao Paulo,
Rua Dr. Ovidio Pires de Campos 785, 05453-010 Sa˜o
Paulo, SP, Brazil
S. Al-Saraj
Department of Clinical Neuropathology,
London Institute of Psychiatry,
London, UK
123
Cell Tissue Bank (2011) 12:289–297
DOI 10.1007/s10561-010-9199-z
recommended. We found that methyltransferase- and
acetyltransferase-activities were relatively preserved
with PMI and storage duration. In conclusion, preser-
vation of acetyltransferase- and methyltransferase-
activities provides possible evidence of stability for
epigenetic studies using postmortem tissue.
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Introduction
Postmortem brain tissue has been reported to be
suitable to delineate regional pattern of possible
disturbances underlying epigenetic functionality
(Keller et al. 2010; Barrachina and Ferrer 2009; Zhubi
et al. 2009; McGowan et al. 2009; Ernst et al. 2009;
Tamura et al. 2007). However, several studies report an
effect of postmortem interval (PMI), storage time and
premortem variables on human postmortem brain
tissue preservation of DNA, RNA and proteins (Ferrer
et al. 2008; Beach et al. 2008; Waldvogel et al. 2008;
Grinberg et al. 2007; Chandana et al. 2009). To reduce
any false positive or negative results it is important to
check the biomarker of interest that best mimics the
brain region (Kretzschmar 2009). The use of advanced
molecular and biochemical methods for studying well
preserved and well characterized human brain tissue
can provide new knowledge regarding the cascade of
events causing neurological or psychiatric disorders.
Therefore, Brain Banks are, without any doubt, most
valuable for researchers in this field. In the past, there
were several limitations and debate concerning brain-
banking protocols, especially regarding tissue quality
control (Kretzschmar 2009; Bell et al. 2008; Schmitt
et al. 2007; Pope et al. 1997).
Premortem and postmortem parameters, such as
agonal state or PMI were studied more recently for their
influence on DNA, RNA, protein levels, and enzyme
quality (Gru¨nblatt et al. 2009; Monoranu et al. 2009;
Ferrer et al. 2007a, b; Ervin et al. 2007; Buesa et al.
2004). Preservation of DNA methylation in several gene
promoters has recently also been investigated in
postmortem brain (Barrachina and Ferrer 2009). In our
recent study, we could show that tryptophan (TRP)
levels in brain tissue correlate to PMI and storage
duration. Since we postulated that elevated TRP may
mirror increased protein degradation as consequence of
prolonged PMI and storage duration the question arose
whether high and low TRP levels correlate to certain
parameters such as RNA, protein and epigenetic
markers. Therefore, selected samples with high and
low levels of TRP in well characterized postmortem
human brain tissue originating from the European Brain
Bank consortium II (BNEII) were studied. Correlations
have been examined between PMI, storage duration and
RNA quality; neurochemical markers such as TRP
concentration, glutamate decarboxylase (GAD; EC 4.1.
1.15) and phosphofructokinase-1 (PFK; EC 2.7.1.11)
enzyme activities (Gru¨nblatt et al. 2009); tissue pH
(Monoranu et al. 2009); protein levels/degradation of
selected proteins involved in neurodegenerative dis-
eases and psychiatric disorders; and enzymatic activities
of acetyltransferase and methyltransferase which are
involved in the process of DNA acetylation and
methylation (epigenetic markers). Through these asso-
ciation studies, we aim to elucidate whether TRP levels
do correlate to protein degradation as well as to RNA
and DNA-modulator stability. In addition since the
stability of epigenetic markers in postmortem brain
tissue is not yet known, we explored this possibility.
Materials and methods
Brain tissue samples
Postmortem human brain tissue was obtained from
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in BNE II: London, Wu¨rzburg Department of Neu-
ropathology (NP) and Go¨ttingen (Bell et al. 2008).
Whole human brains were obtained with the consent
of relatives according to the guidelines of the NIH
Guide for Use of human tissue (NIH 2001) and were
approved by the national and local ethics committees.
Cause of death was determined from clinical notes,
the autopsy report, or the death certificate.
In preparation for routine neuropathological exam-
ination, the brain was divided midsagittally, and one
half-brain was immersed in 4.5% paraformaldehyde
(Fischar GmbH, Saarbru¨cken, Germany) for 3–4
weeks. The remaining half was cryopreserved follow-
ing coronal slicing for cortical sampling, sagittal
slicing for sampling the cerebellum and transverse
sectioning of the brain stem. Tissue samples were snap
frozen on brass plates, cooled on dry ice, and stored
at -80C until requested for experimental use. A
neuropathological assessment was completed by mac-
roscopic and histological examination of paraffin-
embedded tissue. Because the tissue was obtained from
different institutions, detailed information concerning
tissue preparation and storage was collected. All
samples described in this study were shipped on dry
ice in frozen state without any defrost phase, and
were processed and analyzed in the Neurochemistry
Laboratory of the Clinic for Psychiatry, University
Wu¨rzburg (Germany) as well as in the Institute of
Neuropathology, University Barcelona (Spain).
Twelve cases were available (Table 1), with ‘con-
trol’ defined as no history of any neurological or
neuropsychiatric disease plus confirmation by histo-
pathological examination. The gender distribution was
balanced with samples from 6 males and 6 females.
After determining that brain region had no effect on
TRP levels or on GAD or PFK activity, the mean
values for each case were calculated using measure-
ments from the different brain regions (Gru¨nblatt et al.
2009). Detailed information about age (ranging from
32 to 84 years), PMI (range from 5 to 100 h) and
storage time (range from 9 to 120 months) was
provided for all cases. Sample characteristics are
summarized in Table 1.
pH measurements
Tissue pH values were determined for fresh dissected
tissue or for thawed frozen blocks of tissue using a T
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pH meter as previously described (Gru¨nblatt et al.
2009; Monoranu et al. 2009).
TRP concentration determination
The TRP measurements were conducted according to
the method described previously for tissue-free amino
acid determination (Gru¨nblatt et al. 2009). TRP tissue
levels were calculated for all samples in lM concen-
tration (all samples were of 52.63 mg tissue/ml).
GAD activity assay
GAD activity was determined by measuring the produc-
tion of radiolabeled carbon dioxide from 14C-glutamate
as described previously (Gru¨nblatt et al. 2009). Assays
were conducted in triplicate for each sample, and results
were normalized for the total protein content measured
via Bradford (Bradford 1976). Enzyme activity was
expressed as nmol/mg protein/hour.
PFK activity assay
Determination of PFK activity by measuring the
production of radiolabeled D-fructose-1,6-biphos-
phate from [c-32P]-ATP was performed as described
previously (Gru¨nblatt et al. 2009). Assays were
conducted in triplicate for each sample, and results
were normalized for total protein content measured via
Bradford. Enzyme activity was expressed as nmol
fructose-1,6-bisphosphate/mg protein/minute.
Western blot analysis
Gel electrophoresis and western blotting was carried
out as reported elsewhere (Ferrer et al. 2007b). The
following proteins were analyzed with appropriate
antibodies: RAB3A (rabbit polyclonal, Santa Cruz
Biotechnology, Heidelberg, Germany, diluted 1:200),
synaptophysin (mouse monoclonal, Dako, Dakopats,
Barcelona, Spain diluted 1:6,000),a-synuclein (mouse
monoclonal, Neomarkers, Fredmont, CA, USA,
diluted 1:3,000),a-synuclein (rabbit polyclonal, Chem-
icon, Barcelona, Spain, diluted 1:2,000), glial fibrillary
acidic protein (GFAP, mouse monoclonal, Dako,
diluted 1:30,000), TAU-P-ser262 (rabbit polyclonal,
Calbiochem, LaJolla, CA, USA, diluted 1:500),
TAU46 (mouse monoclonal, Abcam, Cambridge,
UK, diluted 1:1:1,000), calcium calmodulin kinase
IIa(CamK-IIa, rabbit polyclonal, Santa Cruz, diluted
1:500) a-Tubulin (mouse monoclonal, Sigma, Madrid,
Spain, dilution 1:10,000), b-Tubulin (rabbit poly-
clonal, Abcam, diluted 1:10,000), metabotropic gluta-
mate receptor 2–3 (mGlu R2/R3, rabbit polyclonal,
Upstate, Millipore, Barcelona, Spain, diluted 1:1,000),
TrkB (rabbit polyclonal, Santa Cruz, diluted 1:200)
and brain derived neurotrophic factor (BDNF, rabbit
polyclonal Santa Cruz, diluted 1: 1,000) normalized all
with b-actin (rabbit polyclonal, Dako, diluted 1:
20,000). Protein expression levels were determined
by densitometry of the bands using Total Laboratory
v2.01 software. This software detects the bands
obtained in Western blots and gives individual values
which are dependent on the light quantification of the
corresponding band. Measurements are expressed as
arbitrary units. The results were normalized for b-actin
densitometry.
RNA quality analysis
Total RNA was isolated using RNeasy Mini Kit
(Qiagen, Hilden, Germany), according to the manu-
facturer’s instructions. RNA purity was assessed using
the A260/A280 ratio (A260 = absorbance at 260 nm;
A280 = absorbance at 280 nm). RNA integrity was
analyzed on an Agilent 2100 Bioanalyzer, which also
automatically calculates the sample concentration, the
28S/18S ribosomal ratio, and the RNA Integrity
Number (RIN). RIN values lower than 7 are usually
regarded as degraded RNA/low RNA quality, while
values over 7 are regarded as good RNA quality.
Acetyltransferase activity
Total acetyltransferase activity was measured accord-
ing to the Acetyltransferase Activity Kit (Assay
Designs Inc. Michigan, USA). For homogenate prep-
aration small frozen brain tissue were added in 19
RIPA buffer in a 1: 10 (weight to volume) dilution and
lysed using Tissue Lyser (Qiagen, Hilden, Germany) at
25 Hz for 30 min. Total protein was determined via
Bradford. The acetyltransferase activity test was run in
triplicates with total protein concentration of 1 ng/ll.
An end-point measurement was performed and fluo-
rescence was read at 380ex/520em according to the
manufacture’s instructions.
292 Cell Tissue Bank (2011) 12:289–297
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Methyltransferase activity
Total methyltransferase activity was measured according
to the Methyltransferase Activity Kit (Assay Designs Inc.
Michigan, USA). Homogenate preparation and measure-
ments were performed as the acetyltransferase activity
assay.
Statistical methods
For analysis of high and low TRP levels on various
parameters one-way ANOVA was used. Correlations
were calculated using Spearman’s correlation coeffi-
cient. P-values lower than 0.05 were considered
statistically significant. The analysis was conducted
using SPSS 15.0 software (SPSS Inc. Headquarters,
Chicago, IL, USA).
Results
TRP correlation to postmortem factors
In this study we selected six brain tissue samples with
high levels of TRP (213 ± 30.7 lM) and six with low
TRP levels (31.3 ± 16.6; P \ 0.0001; Supplementary
Table S1). Gender, agonal state (rapid versus prolonged)
and freezing method did not affect TRP levels (Supple-
mentary Table S1). We could observe significantly
longer storage duration for the group of high TRP levels
in comparison to the low TRP (94 ± 20.7 months;
40.2 ± 23.7 months; respectively, P = 0.002; Supple-
mentary Table S2). Nominal significant longer PMI was
observed for the high TRP group versus the low TRP
group (46.5 ± 30.4; 21.2 ± 15.9 h; respectively,
P = 0.101; Supplementary Table S2). Age, pH value,
PFK, GAD activity, RNA quality and protein variables
did not affect TRP levels when divided into high- and
low-levels (Supplementary Table S2; for raw data see
supplementary Table S3).
Effects of PMI and storage duration
on preservation of RNA, neurochemical
and protein markers
Spearman correlation analysis was conducted
between postmortem parameters such as storage
period and PMI to neurochemical parameters com-
monly measured by scientists in brain tissue. Table 2
summarizes the correlation results between selected
markers (for all correlations see supplementary Table
S4). TRP levels significantly correlated positive to
storage period (Rho = 0.697, P = 0.008). TAU46,
TAU-p ser262 and a-Tubulin protein levels measured
via western blotting significantly correlated with PMI
(Rho = -0.669, -0.634, -0.636; P = 0.017, 0.027,
0.035, respectively). All three proteins show decrease
in their levels with longer periods of PMI.
Brain tissue pH-values did not show any correlation
to any of the markers studied. RNA concentration and
RNA quality measured as RIN were found to correlate
with each other (Rho = 0.558, P = 0.047), which
means RNA quality increases with RNA concentration
in postmortem brain tissue. But RNA quality did not
alter with prolonged PMI or storage duration (Supple-
mentary Table S4).
Effects of PMI, storage duration and enzyme
activity on preservation of epigenetic markers
In order to study whether methyl- and acetyltransferase
activities, as epigenetic markers, alter as a result of
postmortem factors, we correlated enzyme activity at
different PMI and to storage duration. No modifica-
tions in acetyltransferase activity and methyltransfer-
ase activity were noticed with increasing postmortem
delay or duration of storage (Table 2).
We found a correlation between GAD activity to the
methyltransferase activity (Rho = 0.698, P = 0.008),
in which increase of one follows the other (Table 2).
Correlations between protein preservation
Regarding protein levels in postmortem brain tissue,
we found correlations between several proteins. Syn-
aptophysin levels increase with increased mGlu R2/R3
levels (Rho = 0.773, P = 0.005). Increased GFAP
levels correlated significantly with decreased levels of
a-Synuclein, TAU46 and a-Tubulin (Rho = -0.836,
-0.636, -0.827, P = 0.001, 0.035, 0.002, respec-
tively). In addition, TAU46 levels correlate signifi-
cantly with a-Synuclein, TAU-P ser262 and a-Tubulin
(Rho = 0.827, 0.647, 0.827, P = 0.002, 0.02, 0.002,
respectively), in which increased levels of TAU46
associate with increased levels of the listed proteins.
Similarly to TAU46, a-Tubulin was significantly
correlated with a-Synuclein and TAU-P ser262
(Rho = 0.855, 0.700, P = 0.001, 0.016, respectively).
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TrkB levels correlated to increased levels of b-Tubulin
and mGlu R2/R3 (Rho = 0.819, 0.709, P = 0.001,
0.007, respectively). As well as, b-Tubulin correlated
significantly to mGlu R2/R3 (Rho = 0.797, P =
0.001; Table 2; Supplementary Table S4).
Discussion
In the current study, we demonstrated again that TRP
levels may be used as a marker for PMI and storage
duration of postmortem brain tissue quality. Increased
TRP levels in postmortem tissue seem to indicate
protein degradation and enzyme activity alterations, as
previously reported (Ferrer et al. 2007a; Birkmayer and
Riederer 1980). This finding was concomitant with
degradation of some proteins, TAU-P-ser262 and
a-tubulin that were significantly reduced as a result
of increased PMI. This finding is confirmation of
previously published studies demonstrating degrada-
tion of proteins with prolonged PMI (Ferrer et al.
2007a; Crecelius et al. 2008; Santpere et al. 2006).
However, it is notable that not all proteins degrade in a
similar manner (Omalu et al. 2005); therefore scientists
should test the protein/enzyme of interest ahead for its
sensitivity to degrade as consequence of pre-mortem of
postmortem conditions.
The importance of RNA quality in human post-
mortem brains research is not questionable (Ferrer
et al. 2008; Ervin et al. 2007; Barton et al. 1993; Hynd
et al. 2003; Tomita et al. 2004; Barrachina et al. 2006;
Chevyreva et al. 2008; Popova et al. 2008). In our
study, we could not find any direct influence of
postmortem variables (e.g. PMI, storage, pH-value,
or neurochemical parameters) on the RNA integrity
measured by RIN values. This finding is in accordance
to several reports indicating no correlation to these
parameters (Ferrer et al. 2008; Ervin et al. 2007;
Popova et al. 2008; Stan et al. 2006). Still, the range of
PMI in our study was not lower than 5 h which might
bias our results since RNA degradation occurs rapidly,
while others did not confirm this (Perrett et al. 1988).
Regarding correlations among proteins, the present
results serve to point out that special care must be taken
when considering protein–protein interactions and
construction of protein networks in specific conditions,
based on data obtained from postmortem human brain
material. It is clear that the reconstruction of protein
networks and metabolic pathways is a useful tool to
increase understanding about altered or preserved
metabolic pathways in normal and pathological con-
ditions (Xue et al. 2007; Mohajerani et al. 2007). Yet,
the construction of maps and networks and more
particularly the meaning of decreased or increased
protein levels can be largely hampered by postmortem
artifacts due to selective individual vulnerability of
proteins to premortem and postmortem parameters.
The study of protein conservation with PMI was to
investigate whether there is a common pattern of
degradation among similar groups of proteins or
proteins related to a particular pathway. The present
findings show correlations in the expression levels
among certain cytoskeletal proteins, synaptic and
receptor proteins (especially TAU46, TAU-p ser262
and a-Tubulin were degraded with increased PMI) and
we hypothesize that other proteins may be influenced
as well. Construction of protein networks based on
protein expression levels should consider variations of
protein expression in cluster proteins in postmortem
brain. Probably, preservation or degradation may be
very different from one protein to another thus hamper-
ing any conclusion when one protein is elevated and the
associated protein is reduced within a context in which
the reduced protein is very vulnerable to PMI.
Additional aim of our study to investigate epige-
netic markers alterations with prolonged PMI and
storage duration as well as to TRP level, revealed that
methyltransferase and acetyltransferase activities were
relatively preserved with PMI and storage duration.
The silencing of epigenetically regulated promoters is
associated with high levels of DNA methylation and
decreased acetylation of core histones in their regions
(Li and Bird 2007). Such epigenetic down-regulation
of genes are investigated in mechanisms involved in
the GABAergic neurons in schizophrenia (Kundakovic
et al. 2009), as well as in Tauopathies including
Alzheimer’s disease (Barrachina and Ferrer 2009).
Here, we could show that there are probably no
limitation using human postmortem brain tissue for
epigenetic studies. Still it would be important to
confirm these results in an independent laboratory with
independent brain tissue samples, as well as to
investigate whether in artificial PMI conditions with
time and different storage conditions these two enzyme
stay stable. In addition, validation in epigenetic brain
research would be of interest for further confirmation
of effects through pre-mortem and postmortem
conditions.
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In conclusion, in this study we could demonstrate
that for PMI and storage duration one may use TRP
levels as a quality control marker, since some proteins
seems to be sensitive to prolonged PMI and storage
duration. Via elevated TRP levels the general degra-
dation of proteins might be evaluated, before evalu-
ation of the specific protein/enzyme of interest.
Therefore, scientists using human postmortem brain
tissue for proteomic studies should take in account
such markers. On the other hand, studying epigenetic
alterations seems to be independent of PMI and
storage duration, offering scientists a broad usage of
postmortem brain tissue for their investigations.
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